A recent case report highlights the importance of understanding the possibility of the development of Euglycemic diabetic ...

Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) fell 6% during trading on Wednesday after the company announced weaker than expected quarterly earnings. The stock traded as low as $769.00 ...

Hunter Associates Investment Management LLC trimmed its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 0.8% in ...

In response to public pressure and changing market dynamics, the trio of major manufacturers slashed insulin prices by 70% or more last ... Novo Nordisk plans to spend $30 billion on factories ...

Some diabetes patients this year have had trouble finding their preferred insulin brands as major drug manufacturers reported shortages of the medicine. USA TODAY set out to find out what patients ...

In response to public pressure and changing market dynamics, the trio of major manufacturers slashed insulin prices by 70% or ...

PHILADELPHIA (AP) — A Philadelphia jail caused the death of a diabetic inmate by failing to provide insulin and other medical care, according to a federal lawsuit filed by the man's family ...

Now, scientists have made a major breakthrough in developing what has been long called the “holy grail” diabetes treatments — a “smart” insulin that responds in real time to fluctuations in one’s ...

at 3:30 PM GMT. As one of the first operating systems based on the Android 15 update, OxygenOS 15 leverages OnePlus's extensive research and deep user insights to create a new generation of ...

A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...

“Notably, glucose values vary over a narrow range (from approximately 2 to 20-30 mM [36 mg/dL to 360-540 mg/dL] in people with diabetes), so a rather steep change in insulin bioactivity must be ...

There's a diet gaining much attention on social media, and it's called "30-30-30." What's so special about it? Well, Gary Brecka, human biologist and co-founder of 10X Health Systems, explains in a ...